In vivo behavior of poly(å-caprolactone-co-DL-lactide)/bioactive glass composites in rat subcutaneous tissue

Journal of Bioactive and Compatible Polymers

Volumn 22, Issue 3, 2007, Pages 249-264

  Ranne, T ^a   Tirri, T ^a   Yli Urpo, A ^a   Narhi T O ^a   Laine, V J O ^a   Rich, J ^b   Seppala J ^b   Aho, A ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b AALTO UNIVERSITY   (Finland)

Author keywords

caprolactone; Bioactive glass; Composite; Connective tissue; Copolymer; Implants; Lactide

Indexed keywords

CAPROLACTONE; CONNECTIVE TISSUE; IMPLANTS; LACTIDES;

BIOACTIVITY; COPOLYMERS; GROWTH KINETICS; REACTION KINETICS; TISSUE;

BIOACTIVE GLASS;

BIOPOLYMER; GLASS; POLY(CAPROLACTONE CO LACTIDE); POLYCAPROLACTONE; POLYLACTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPOSITE GRAFT; FEMALE; MALE; MATERIALS TESTING; NONHUMAN; RAT; SUBCUTANEOUS TISSUE; TISSUE GROWTH; WOUND HEALING;

RATTUS;

EID: 34250617036     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911507078270     Document Type: Article

References (31)

1. (a) Rossini, A.A., Greiner, D.L., and Mordes, J.P. (1999). Induction of immunologic tolerance for transplantation. Physiol. Rev., 79 (1). 99 - 141.
2. (b) Chiellini, F. (2006). Perspectives on in vitro evaluation of biomedical polymers. J. Bioact. Comp. Polym., 21: 257 - 271.
3. Böstman, O. and Pihlajamäki, H. (2000). Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials, 21: 2615 - 2621.
4. Vert, M., Christel, P., Chabot, F., and Leray, J. (1984). Bioresorbable plastic materials for bone surgery. In: Mastings, G.W., Dycheyne, P., eds. Macromolecular Biomaterials, pp. 119 - 142, CRC Press, Inc., Boca Raton, FL.
5. Hench, L.L. and Paschall, H.A. (1974). Histochemical responses at a biomaterials interface. J. Biomed. Mater. Res., 8 (3). 49 - 64.
6. Schepers, E.J. and Ducheyne, P. (1997). Bioactive glass particles of narrow size range for the treatment of oral bone defects: a 1-24 month experiment with several materials and particle sizes and size ranges. J. Oral Rehabi., 24 (3). 171 - 181.
7. Furusawa, T. and Mizunuma, K. (1997). Osteoconductive properties and efficacy of resorbable bioactive glass as a bone-grafting material. Implant Dent., 6: 93 - 101.
8. Andersson, Ö.H. and Kangasniemi, I. (1991). Calcium phosphate formation at the surface of bioactive glass in vitro. J. Biomed. Mater. Res., 25: 1019 - 1030.
9. Peltola, M., Suonpää,J., Aitasalo, K., Vapula, M., Yli-Urpo, A., and Happonen, R.-P. (1998). Obliteration of the frontal sinus cavity with bioactive glass. Head Neck, 20: 315 - 319.
10. Aitasalo, K., Kinnunen, I., Palmgren, J., and Varpula, M. (2001). Repair of orbital floor fractures with bioactive glass implants. J. Oral Maxillofac. Surg., 59: 1390 - 1395.
11. Stoor, P., Söderling, E., and Grénman, R. (1999). Interactions between the bioactive glass and the S53P4 and the atrophic rhinitis-associated microorganism Klebsiella ozaenae. J. Biomed. Mater. Res. Appl. Biomater., 48: 869 - 874.
12. Gatti, A.M., Valdré, G., and Andersson, Ö.H. (1994). Analysis of the in vivo reactions of a bioactive glass in soft and hard tissue. Biomaterials, 15 (3). 208 - 212.
13. Stoor, P., Söderling, E., Andersson, Ö.H., and Yli-Urpo, A. (1995). Interactions between the frontal sinusitis-associated pathogen Haemophilus influenzae and the bioactive glass S53P4. In: 8th International Symposium of Ceramics in Medicine, pp. 253-258, Elsevier Science, Ponte Verde, Oxford, USA.
14. Woodward, S.C., Brewer, P.S., Moatamed, F., Schindler, A., and Pitt, C.G. (1985). The intracellular degradation of poly(ε-caprolactone). J. Biomed. Mater. Res., 19: 437 - 444.
15. Domb, J.A., Kumar, N., Sheskin, T., Bentolila, A., Slager, J., and Teomim, D. (2002). Biodegradable polymers as drug carrier system. In: Dumilriu, S., eds. Polymeric Biomaterials, 2 nd edn, pp. 91 - 121, Marcel Dekker Inc., New York.
16. Pitt, C.G., Jeffcoat, A.R., Zweidinger, R.A., and Schindler, A. (1979). Sustained drug delivery systems. I. The permeability of poly(å- caprolactone), poly(DL-lactic acid), and their copolymers. J. Biomed. Mater. Res., 13: 497 - 507.
17. Ozawa, T., Mickle, D., Weisel, R.D., Koyama, N., Ozawa, S., and Li, R. (2002). Optimal biomaterial for creation of autologous cardiac grafts. Circulation, 106 (12 Suppl. I). 176 - 182.
18. den Dunnen, W.F.A., Stokroos, I., Blaauw, E.H., Holwerda, A., Pennings, A.J., Robinson, P.H., and Schakenraad, J.M. (1996 a). Light-microscopic and electron-microscopic evaluation of short-term nerve regeneration using a biodegradable poly(DL-lactide-ε-caprolactone) nerve guide. J. Biomed. Mater. Res., 31: 105 - 115.
19. Nordström, P., Pihlajamäki, H., Toivonen, T., Törmälä, P., and Rokkanen, P. (1998). Tissue response to polyglycolide and polylactide pins in cancellous bone. Arch. Orthoped. Trauma Surg., 117: 197 - 204.
20. Närhi, T.O., Jansen, J., Jaakkola, T., de Ruijter, A., Rich, J., Seppälä, J., and Yli-Urpo, A. (2003) Bone response to degradable thermoplastic composite in rabbits. Biomaterials, 24: 1697 - 1704.
21. Rich, J., Jaakkola, T., Tirri, T., Närhi, T.O., Yli-Urpo, A., and Seppälä, J. (2002). In vitro evaluation of poly(ε-caprolactone- co-DL-lactide)/bioactive glass composites. Biomaterials, 23: 2143 - 2150.
22. Pitt, C.G., Chaslow, F.I., Hibionada, Y.M., Klimas, D.M., and Schindler, A. (1981). Aliphatic polyesters. I. The degradation of poly(ε-caprolactone) in vivo. J. Appl. Polym. Sci., 26: 3779 - 3787.
23. Pitt, C.G., Gratzl, M.M., Kimmel, G.L., Surles, J., and Schindler, A. (1981). Aliphatic polyesters II. The degradation of poly(DL-lactide), poly (å-caprolactone), and their copolymers in vivo. Biomaterials, 2: 215 - 220.
24. Ekholm, M., Hietanen, J., Lindqvist, C., Rautavuori, J., Santavirta, S., and Suuronen, R. (1999). Histological study of tissue reactions to å-caprolactone-lactide copolymer in paste form. Biomaterials, 20: 1257 - 1262.
25. Holland, S.J., Tighe, B.J., and Gould, P.L. (1986). Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems. Review. J. Control. Release, 4: 155 - 180.
26. Qiu, Q.-Q., Ducheyne, P., and Ayyaswamy, P.S. (2000). New bioactive, degradable composite microspheres as tissue engineering substrates. J. Biomed. Mater. Res., 52 (1). 66 - 76.
27. Jaakkola, T., Rich, J., Tirri, T., Närhi, T.O., Jokinen, M., Seppälä, J., and Yli-Urpo, A. (2004). In vitro Ca-P precipitation on biodegradable thermoplastic composite of poly(ε-caprolactone-co-DL-lactide) and bioactive glass (S53P4). Biomaterials, 25: 575 - 581.
28. den Dunnen, W.F.A., Robinson, P.H., van Wessel, R., Pennings, A.J., van Leeuwen, M.B.M., and Schakenraad, J.M. (1996 b). Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(DL-lactide-ε-caprolactone). J. Biomed. Mater. Res., 36: 337 - 346.
29. Andersson, Ö.H., Vähätalo, K., Yli-Urpo, A., Happonen, R.-P., and Karlsson, K.H. (1994). Short-term reaction kinetics of bioactive glass in simulated body fluid and in subcutaneous tissue. Bioceramics, 7: 67 - 72.
30. Marone, G., Casolaro, V., Patella, V., Florio, G., and Triggiani, M. (1997). Molecular and cellular biology of mast cells and basophils. Int. Arch. Allergy Immunol., 114 (3). 207 - 217.
31. Ali, S.A.M., Doherty, P.J., and Williams, D.F. (1994). Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo. Biomaterials, 15 (10). 779 - 785.